证券代码：002777 证券简称：久远银海 公告编号：2025-025 四川久远银海软件股份有限公司 关于全资子公司完成工商变更登记并换发营业执照的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 注册资本：伍仟万元整 成立日期：2014 年 04 月 24 日 经营范围：计算机系统软件、硬件系统、网络设备、监控设备、办公用品的销售及技术 服务；计算机软、硬件的开发、销售、技术服务及技术咨询；弱电工程设计与施工。（以上 经营范围，需许可、备案的取得许可、备案后经营，需资质的凭资质经营）（依法须经批准 的项目，经相关部门批准后方可开展经营活动）。 二、备查文件 一、基本情况 四川久远银海软件股份有限公司（以下简称"公司"）全资子公司四川久远银海畅辉软 件有限公司（以下简称"银海畅辉公司"）因经营需要，于近日完成了法定代表人变更的工 商登记手续，并取得了绵阳市涪城区政务服务和行政审批局核准换发的《营业执照》，本次 工商登记变更除法定代表人变更外，其他登记事项未发生变更。变更后的营业执照基本信息 如下： 公司名称：四川久远银海畅辉软件有限公司 统一社会信用代码： ...

Core Viewpoint - The implementation of drug traceability codes starting from July 1, 2025, is expected to enhance the traceability of medical insurance drugs, strengthen drug circulation supervision, and have a profound impact on the pharmaceutical industry chain, including production, circulation, retail, and medical insurance [1][5][6]. Group 1: Implementation and Impact - The National Medical Insurance Administration has mandated that drug traceability codes must be scanned for medical insurance fund settlement starting July 1, 2025, with full collection and upload of traceability codes required by January 1, 2026 [1][5]. - The traceability code serves as an "electronic ID" for each box of medicine, ensuring unique scanning records to prevent counterfeit drugs and ensure proper drug flow [2][5]. - The traceability system is expected to reduce channel management costs by over 20% and improve operational efficiency by over 30% for companies that fully implement data uploads [3]. Group 2: Industry Response - Several listed companies are actively responding to the regulatory changes, showcasing their efforts in drug traceability and related fields [3][4]. - Companies like Guizhou Xinbang Pharmaceutical have reported significant improvements in procurement, production, storage, and circulation processes due to the new traceability platform [3]. - National Health has emphasized its commitment to data integration and service upgrades to support the traceability initiative, indicating a deep layout in drug regulatory information technology [4]. Group 3: Regulatory and Financial Implications - The traceability code is expected to enhance transparency in drug circulation, reduce logistics costs, and promote fair competition based on quality, price, and service [6][7]. - The integration of traceability data is anticipated to facilitate innovative regulatory models and improve the precision of medical insurance management [6][7]. - The shift towards data-driven credit assessments in the pharmaceutical supply chain is expected to alleviate financing challenges for pharmaceutical companies and foster diverse financial products [7].

Core Viewpoint - Sichuan Jiuyuan Yinhai Software Co., Ltd. has been recognized as a "2024 Sichuan ESG Benchmark Enterprise," highlighting its commitment to environmental, social, and governance (ESG) practices in its operations [3][4]. Group 1: ESG Commitment - The company has made significant investments in green development, social responsibility, and governance practices, which have been acknowledged through the ESG award [3]. - Jiuyuan Yinhai focuses on three main areas: healthcare insurance, digital government, and smart cities, serving over 700 million people across 29 provinces and 240+ cities [3][4]. Group 2: Environmental Responsibility - The company has implemented measures to promote energy conservation and resource utilization, achieving a reduction in carbon emissions by 66,552.17 kg in 2024, representing a 5.71% savings rate [4]. - Initiatives include promoting low-carbon office practices, encouraging healthy low-carbon diets, and creating a comfortable working environment [4]. Group 3: Social Responsibility - Jiuyuan Yinhai has contributed significantly to public welfare through its work in healthcare and digital governance, supporting the operation of national healthcare information platforms across 23 provinces [4]. - The company has won six awards at the "2024 National Smart Healthcare Competition," becoming the most awarded entity, and has developed various social security systems benefiting over ten million users [4]. Group 4: Governance Improvement - In 2024, the company has enhanced its governance level by introducing new policies and revising management methods to strengthen execution and control over critical processes [5]. - Jiuyuan Yinhai has maintained a AAA credit rating in the software service industry for 14 consecutive years, reflecting its operational excellence and governance standards [5].

Group 1 - Fengcai Technology is conducting an H-share issuance with a maximum price of 120.50 HKD per share, aiming to raise funds for its specialized chip business [1] - The global offering consists of 16.3 million shares, with 1.63 million shares available for public offering in Hong Kong [1] - Zijin Mining plans to acquire the Raygorodok gold mine project in Kazakhstan for 1.2 billion USD, enhancing its resource portfolio [1][2] Group 2 - Mindray Medical's shareholder plans to reduce holdings by up to 5 million shares, approximately 0.41% of the total share capital, due to personal funding needs [3] - Degute is planning to acquire control of Haowei Technology through a combination of cash and share issuance, leading to a temporary suspension of its stock [4] - New Dairy's controlling shareholder intends to reduce its stake by up to 3% of the total share capital, also for funding purposes [5] Group 3 - Yueyang Xinchang has resumed production after completing maintenance on its main production facilities, positively impacting its operations [6] - Chengdu Xian Dao has terminated its major asset restructuring plan due to failure to reach agreement on key terms [7] - Maglev Technology's shareholder plans to reduce its stake by up to 3% of the total share capital for personal financial arrangements [9] Group 4 - Zhongyan Dadi announced a cash dividend of 2.82 CNY per 10 shares and a capital increase of 3.99 shares per 10 shares [10] - Yunda Co. plans to distribute a cash dividend of 0.6 CNY per 10 shares, totaling approximately 47.22 million CNY [12] - Victory Co. intends to distribute a cash dividend of 0.42 CNY per 10 shares, amounting to around 36.06 million CNY [13] Group 5 - Shagang Group has invested 2.67 billion CNY in financial products while planning to use up to 8 billion CNY of idle funds for further investments [14] - Jiuyuan Yinhai's subsidiary won an 8.43 million CNY project contract, constituting a related party transaction [15] - China Railway Signal & Communication has announced the resignation of a board member due to personal reasons [16] Group 6 - China Rare Earth clarified that recent management changes have not affected its operations, ensuring stability in production [17] - Qixiang Tengda plans to conduct routine maintenance on its 60,000-ton acetone plant for 60 days to enhance operational safety [19] - ST King Kong's subsidiary signed a 399 million CNY contract for computing power services, indicating growth in its service offerings [20] Group 7 - Ziguang Guowei repurchased 775,500 shares for approximately 49.62 million CNY, reflecting confidence in its market position [22] - Qin Port's major shareholder plans to reduce its stake by up to 2% of the total share capital for development needs [22] - Longqi Technology has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange, expanding its market presence [24]

Group 1 - The board meeting of Sichuan Jiuyuan Yinhai Software Co., Ltd. was held on June 27, 2025, via communication method, with all 9 directors participating in the voting [1] - The board approved a proposal related to a connected transaction, with a voting result of 7 votes in favor, 0 against, 0 abstentions, and 2 abstentions due to conflict of interest [1] - The independent directors had previously reviewed the proposal in a dedicated meeting, with a voting result of 5 votes in favor, 0 against, 0 abstentions, and 4 abstentions due to conflict of interest [2] Group 2 - The announcement regarding the connected transaction will be disclosed in various financial newspapers and on the official website [1] - The board meeting adhered to relevant laws, regulations, and the company's articles of association [1] - The company ensures that the information disclosed is true, accurate, and complete, with no false records or significant omissions [1]

Group 1 - The company, Sichuan Jiuyuan Yinhai Software Co., Ltd., is set to enter into a procurement contract with a subsidiary of the China Engineering Physics Research Institute, with a total contract value of approximately 8.43 million yuan [1][3] - The China Engineering Physics Research Institute, established in 1958, is a key national military research institute focused on advanced defense science and technology [2] - The procurement contract was determined through a competitive negotiation process, ensuring fair pricing and compliance with market principles [3][4] Group 2 - The company has reported a total of 1.644 million yuan in various related transactions with the same related party from the beginning of the year to the disclosure date [3] - Independent directors have reviewed the related transaction and unanimously agreed that it aligns with the company's operational situation and does not harm the interests of shareholders [4]

证券代码：002777 证券简称：久远银海 公告编号：2025-024 四川久远银海软件股份有限公司 关于关联交易的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、关联交易概述 1．关联交易的主要内容 根据近日中国工程物理研究院（以下简称"中物院"）下属单位发布的成交通知书， 四川久远银海软件股份有限公司（以下简称"公司"）控股子公司四川兴政信息技术有 限公司确定为"XX 项目采购合同"供应商，拟与中物院下属单位签订合同，合同总金额 预计 843.00 万元。 2．交易各方关联关系 2025 年 6 月 27 日，公司独立董事就本次关联交易召开第六届董事会独立董事第十次 专门会议，以 3 票赞成、0 票反对、0 票弃权审议通过了《关于关联交易的议案》，同意 将该议案提交公司董事会审议。 公司于 2025 年 6 月 27 日召开第六届董事会第十二次会议，以 5 票赞成、0 票反对、 0 票弃权、4 票回避审议通过了《关于关联交易的议案》。公司董事李海燕女士、宋小沛 先生、袁宗宣先生和陈泉根先生为关联董事，对该议案回避表决。 4．本次关联交易未构成《上 ...

四川久远银海软件股份有限公司 第六届董事会独立董事第十次专门会议决议 根据《上市公司独立董事管理办法》《深圳证券交易所股票上市规则》等相关法 律法规、规范性文件以及《四川久远银海软件股份有限公司独立董事专门会议工作制 度》的相关规定，四川久远银海软件股份有限公司（以下简称"公司"或"本公司"） 于2025年6月27日以通讯方式召开第六届董事会独立董事第十次专门会议。 本次会议由公司过半数独立董事共同推举独立董事张腾文召集并主持。应出席独 立董事3人，实际出席独立董事3人。 全体独立董事本着认真、负责的态度，在认真阅读公司提供的资料，听取有关人 员的汇报并详细了解有关情况后，经出席会议的独立董事审议和表决，形成以下决议： 一、审议通过《关于公司2025年度经营团队业绩考核方案的议案》 表决结果：同意3票，反对0票，弃权0票。 独立董事发表同意意见如下： 经营团队业绩考核方案是依据公司所处行业及市场同类企业薪酬水平，并结合公 司的实际经营情况和相关人员的履职情况制定的，符合公司的薪酬政策和激励机制。 不存在损害公司及股东利益情形，符合相关法律、法规及《公司章程》的规定。同意 将该方案提交董事会审议。在审议上述议案 ...

证券代码：002777 证券简称：久远银海 公告编号：2025-023 四川久远银海软件股份有限公司 第六届董事会第十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 一、董事会会议召开情况 四川久远银海软件股份有限公司第六届董事会第十二次会议通知于 2025 年 6 月 17 日以专人送达、电话、电子邮件等方式送达全体董事、监事及全体高级管理人员。 会议于 2025 年 6 月 27 日以通讯方式召开，会议应参加表决的董事 9 人，实际参加 表决的董事 9 人。会议由董事长连春华先生主持，会议的召集、召开符合有关法律、 法规和《公司章程》的规定。 二、董事会会议审议情况 会议以记名投票方式对议案进行表决，审议通过如下议案： 关联董事宋小沛、李海燕、袁宗宣、陈泉根回避表决本议案。 三、备查文件 1、第六届董事会第十二次会议决议； 表决结果：7票同意，0 票反对，0 票弃权，2票回避。 关联董事连春华、乔登俭回避表决本议案。 2. 审议通过《关于关联交易的议案》 具体内容详见《证券时报》《中国证券报》《上海证券报》《证券日报》和巨潮资 讯网（w ...

Group 1 - The core viewpoint of the article highlights a significant increase in the performance of medical information technology concept stocks, with notable gains in specific companies [1] - Weining Health experienced a rise of over 10%, indicating strong market interest and investor confidence in the sector [1] - Other companies such as Dian Diagnostics and Chuangye Huikang also saw increases of over 5%, reflecting a broader positive trend in the medical information technology industry [1] Group 2 - Additional companies that followed the upward trend include Sichuang Medical, Guoxin Health, Jiuyuan Yinhai, Wanda Information, and Saili Medical, showcasing a collective movement within the sector [1]